Scientists show proteins critical in day-night cycles also protect cells from mutations

March 10, 2015

LA JOLLA, CA - March 10, 2015 - A good night's sleep does more than prevent yawning. New research from The Scripps Research Institute (TSRI) shows that two proteins critical for maintaining healthy day-night cycles also protect against mutations that could lead to cancer.

The new study, published March 10, 2015, in the journal eLife, shows that the two proteins have an unexpected role in DNA repair, possibly protecting cells from cancer-causing mutations triggered by UV radiation.

"These proteins play an important role in the response to DNA damage," said TSRI biologist Katja Lamia, senior author of the study. "Researchers might eventually harness that knowledge for pharmaceutical targeting."

Day and Night

The human body senses light and adjusts its rhythms to a day-night cycle called the circadian clock. Feeling tired? Feeling hungry? These feelings are strongly influenced by the body's circadian clock.

Studies show that people with unusual sleep schedules, such as flight attendants or night-shift nurses, are at risk for certain health problems.

"When you have a deregulation of your circadian clock, you're more prone to develop some kind of pathology, like diabetes, cancer or heart disease," said TSRI Research Associate Anne-Laure Huber, who was co-first author of the study with Stephanie Papp, a graduate student at TSRI.

In the new study, the research team investigated a possible cause of these health disparities. They focused on the role of proteins called cryptochromes, which are believed to have evolved from light-activated DNA repair enzymes in bacteria.

Cryptochromes contain a photo-responsive pigment called flavin. While cryptochromes are no longer light-activated, they do hold to a daytime-regulated schedule, and stability of the proteins cryptochrome 1 (Cry1) and cryptochrome 2 (Cry2) is critical for circadian clock function. In the human body, cryptochromes no longer have a direct role in DNA repair either, but they are essential for regulating blood sugar levels and protein production on a day-night cycle.

Repairing DNA

The new study started when the researchers went on what Lamia calls a "fishing expedition." They used a technique called proteomic screening, in collaboration with the laboratory of TSRI Professor John Yates, to test for a wide range of proteins that could bind to Cry1 or Cry2 from mouse and human cells.

The team found that Cry1 could bind with Hausp, a protein with a known role in regulating an anti-cancer protein called p53. The screening also showed that Hausp binds to Cry2, but not as strongly, suggesting that the nearly identical proteins actually have different roles related to DNA repair.

"Most of the time people study them as redundant proteins, but we show that they have distinct functions in this DNA-repair pathway," said Lamia.

Subsequent studies of genetic expression showed that Hausp stabilizes Cry1 by removing protein chains that trigger Cry1 degradation. By stabilizing Cry1, Hausp prevents potential errors in DNA transcription that could occur when DNA is exposed to radiation.

"This is very cool," said Papp. "These proteins can sense that something is wrong in the cells."

The researchers also found that when they blocked Cry2 production in cells, the cells no longer activated p21, a protein that stops mutant cells from dividing. "This could suggest that cells without Cry2 would be more susceptible to cancer," said Lamia.

Together, these findings show that while Cry1 and Cry2 no longer directly repair DNA, they still have an indirect role in the repair process.

This new link between circadian clock proteins and DNA repair is a clue to how disrupting day-night cycles could harm health. Lamia said future studies in her lab will explore additional roles of cryptochromes in the body.
-end-
In addition to Papp, Huber, Yates and Lamia, authors of the study "DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization," were Sabine D. Jordan, Anna Kriebs, Madelena Nguyen and James J. Moresco, all of TSRI.

This research was supported by the Searle Scholars Fund, the Sidney Kimmel Foundation for Cancer Research, the Lung Cancer Research Foundation, the National Institutes of Health's (NIH) National Institute of General Medical Sciences (8 P41 GM103533), the NIH National Institute on Aging (R01AG027463), the NIH National Institute of Diabetes, Digestive and Kidney Diseases (grants K01DK090188-03 and R01DK097164-01) and the Deutsche Forschungsgemeinschaft.

Scripps Research Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.